| Statement 1.14: The choice of monitoring modality (biomarkers, endoscopy, imaging) and the interval between assessments should be individualized based on the site, distribution and severity of the CD, patient preference, local availability of imaging exams/expertise, and cost (Evidence level 5) |
Voting agreement rate 45/45 (100%) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.